Read the Summer Issue.
Continue reading "News from the Ryan Institute: Summer 2018"Author: maranhas
Prescription “Study Drugs” Do Not Improve Cognition in Students Without ADHD
College students without ADHD are increasingly using them as “study drugs” in the hopes of boosting memory and learning. A new study looks at the trend.
Continue reading "Prescription “Study Drugs” Do Not Improve Cognition in Students Without ADHD"Why support the Ryan Institute?
Our research into under-explored factors in brain health depends on the generous individuals who support our work and mission. Private gifts are especially critical to fund early-stage research and scientific innovation that build a foundation for federal and corporate grants. If you would like to learn more about how you can make this research possible, […]
Continue reading "Why support the Ryan Institute?"Brain Fair
Save the date for the 3rd annual Brain Fair: Saturday, March 16, 2019. Details and registration coming soon! This year’s event will be even bigger and better in an expanded space. We’ll feature brain talks on topics from the science of dreaming to the latest on Alzheimer’s disease, plus educational activities for all ages, special […]
Continue reading "Brain Fair"Alzheimer’s Prevention Registry
The Ryan Institute has partnered with the national Alzheimer’s Prevention Registry in the fight against Alzheimer’s disease. How do I join the registry? It’s easy and free. Visit the registry home page at endalznow.org. Why should I sign up? When you sign up for the registry, you’ll receive Alzheimer’s news and research updates, as […]
Continue reading "Alzheimer’s Prevention Registry"Resources
Resources for Patients and Caregivers The Ryan Institute places a high importance on engaging both immediate and peripheral communities affected by neurodegenerative diseases. In order to actively help caregivers, family members and those suffering from these diseases, we have provided access below to some of the best resources, both locally and nationally. Rhode Island THE POINT […]
Continue reading "Resources"test
tgsetsdf
Continue reading "test"MindImmune Receives Licensing for New Research
MindImmune Therapeutics, Inc., a biotech startup based at URI in affiliation with the Ryan Institute, recently acquired licensing for two research programs: a first-in-kind Huntington’s drug and a non-opioid painkiller for neuropathic pain.
Continue reading "MindImmune Receives Licensing for New Research"